| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/18/1996 | WO1996021356A1 Methods and compositions for inducing mucosal immune responses |
| 07/18/1996 | DE19500784A1 Enrofloxacin-Injektions- oder Infusionslösungen Enrofloxacin injection or infusion solutions |
| 07/18/1996 | DE19500662A1 Estradiolhaltiges Pflaster Estradiolhaltiges paving |
| 07/18/1996 | CA2735293A1 Nadh and nadph therapeutic agents for dermal administration |
| 07/18/1996 | CA2210341A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 07/18/1996 | CA2210132A1 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 07/18/1996 | CA2210091A1 New applications of lysozyme dimer |
| 07/18/1996 | CA2209492A1 Compositions for the delivery of antigens |
| 07/18/1996 | CA2209064A1 Methods and compositions for inducing mucosal immune responses |
| 07/18/1996 | CA2208571A1 Resin particle, medical material and pharmaceutical preparation containing said resin particle |
| 07/18/1996 | CA2208060A1 Method of altering composition of nutritional product |
| 07/18/1996 | CA2207599A1 Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| 07/18/1996 | CA2167254A1 Controlled release of steroids from sugar coatings |
| 07/18/1996 | CA2167104A1 Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/17/1996 | EP0721785A2 Delittered ranitidin preparation |
| 07/17/1996 | EP0721784A1 Controlled-release drug preparation |
| 07/17/1996 | EP0721777A2 Use of tomoxetine for the treatment of attention deficit/hyperactivity disorder |
| 07/17/1996 | EP0721776A1 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 07/17/1996 | EP0721501A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 07/17/1996 | EP0721500A1 Insulin-secreting cell lines, methods of production and use |
| 07/17/1996 | EP0721479A1 Polymer membrane having a high permeability for alkanol |
| 07/17/1996 | EP0721464A1 Neuron regulatory factor for promoting neuron survival |
| 07/17/1996 | EP0721351A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 07/17/1996 | EP0721349A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 07/17/1996 | EP0721348A1 Monoglyceride/lactate ester permeation enhancer |
| 07/17/1996 | EP0721343A1 Pharmaceutical formulations of nerve growth factor |
| 07/17/1996 | EP0721338A1 Ranitidine and calcium carbonate pharmaceutical combination product |
| 07/17/1996 | EP0721337A1 Oral formulations of an antifungal |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/17/1996 | EP0721334A1 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor |
| 07/17/1996 | EP0721333A1 Soft-shelled gelatin encapsulated particles |
| 07/17/1996 | EP0721332A1 Process ii |
| 07/17/1996 | EP0721331A1 Process i |
| 07/17/1996 | EP0721330A1 Pharmaceutical composition |
| 07/17/1996 | EP0721329A1 Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists |
| 07/17/1996 | EP0721328A1 Camptothecin formulations |
| 07/17/1996 | EP0721327A1 Aerosol composition for forming a preferably hydrated membrane, preferably hydrated membrane so obtained, and applications thereofparticularly as a dressing |
| 07/17/1996 | EP0721326A1 Contraceptive compositions |
| 07/17/1996 | EP0721325A1 Method of applying an indicia to a fast-dissolving dosage form |
| 07/17/1996 | EP0721324A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 07/17/1996 | EP0721300A1 Substantive antimicrobial phosphates |
| 07/17/1996 | EP0681470B1 Recombinant living subunit vaccine composition and process for its preparation |
| 07/17/1996 | EP0656792B1 A dressing for dosing one or more medicaments |
| 07/17/1996 | EP0601053A4 Compositions and methods for the sublingual or buccal administration of therapeutic agents. |
| 07/17/1996 | CN2231103Y Quick-acting nasal suppository |
| 07/17/1996 | CN2231102Y Lapping agent type anthelmintic salt brick for animals |
| 07/17/1996 | CN2231092Y Hemorrhoid curing napkin |
| 07/17/1996 | CN1127009A Pressure sensitive adhesive composition which is water dispersible under alkaline pH conditions |
| 07/17/1996 | CN1126993A Magnesium omeprazole |
| 07/17/1996 | CN1126948A Methods and compositions for aiding periodontal tissue regeneration |
| 07/17/1996 | CN1126946A New pharmaceutical formulation |
| 07/17/1996 | CN1126617A High-grade life-prolonging health oral liquid |
| 07/17/1996 | CN1126615A Allopelagic health oral liquid |
| 07/17/1996 | CN1126614A Analgesic and antiphlogistic pus-expelling plaster and its prepn process |
| 07/17/1996 | CN1126613A Medicine for curing hepatitis and its prepn process |
| 07/17/1996 | CN1126606A Oral liquid made from plateau plants |
| 07/17/1996 | CN1126602A Chinese medicine composite for lung cancer and its prepn and application |
| 07/17/1996 | CN1126590A Pharmaceutical compositions and a process for the preparation thereof |
| 07/17/1996 | CN1126589A Injecta of delayed hormone microcapsule and its prepn |
| 07/17/1996 | CN1126588A Vitamin replenishing agent |
| 07/17/1996 | CN1126587A Delayed testosterone-releasing system through scrotum |
| 07/16/1996 | US5536753 Stable perfluorocarbon and oil emulsions |
| 07/16/1996 | US5536743 Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| 07/16/1996 | US5536729 Rapamycin formulations for oral administration |
| 07/16/1996 | US5536526 Xylitol-based binding and diluting agent and a process for the production thereof |
| 07/16/1996 | US5536508 Biodegradable polymer and polysaccharide gel and bioadhesive with drug |
| 07/16/1996 | US5536507 Microcrystalline cellulose, delayed release coating, enteric coating |
| 07/16/1996 | US5536505 Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends |
| 07/16/1996 | US5536504 Ultramicroemulsions from spontaneously dispersible concentrates containing xanthophyll esters and having antitumor activity |
| 07/16/1996 | US5536503 Lobeline |
| 07/16/1996 | US5536489 Oil in water, ultrasonic energy |
| 07/16/1996 | US5536469 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system |
| 07/16/1996 | US5536444 Compressed-gas packages using polyoxyethylene glyceryl fatty-acid esters as suspension stabilizers and valve lubricants |
| 07/16/1996 | US5536413 Filtration |
| 07/16/1996 | US5536263 Non-occulusive adhesive patch for applying medication to the skin |
| 07/16/1996 | US5536156 Method of controlling the release of carbohydrates by encapsulation and composition therefor |
| 07/14/1996 | CA2166455A1 Siloxane mq resin vesicles and entrapment |
| 07/11/1996 | WO1996020735A2 Oral gastrointestinal x-ray contrast agents in combination with surfactants |
| 07/11/1996 | WO1996020730A1 A chitosan polymer having a specific degree of acetylation |
| 07/11/1996 | WO1996020727A1 Chicken anaemia agent broiler vaccine |
| 07/11/1996 | WO1996020726A1 Urinastatin-containing suppository |
| 07/11/1996 | WO1996020715A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 07/11/1996 | WO1996020707A1 Pharmaceutical preparations containing nifedipine and process for producing it |
| 07/11/1996 | WO1996020700A1 Pharmacologic management of snoring |
| 07/11/1996 | WO1996020699A1 Composition and methods for transdermal delivery of acid-labile drugs |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996020697A1 Terfenadine oral granules |
| 07/11/1996 | WO1996020696A1 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| 07/11/1996 | WO1996020695A1 Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 07/11/1996 | WO1996020693A1 Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
| 07/11/1996 | WO1996020611A1 Novel bioemulsifiers |
| 07/11/1996 | WO1996010409A3 Liquid antacid compositions containing calcium carbonate and possibly simethicone as active compounds and monobasic potassium phosphate and potassium bicarbonate as buffer |
| 07/11/1996 | CA2209556A1 Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2207905A1 Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 07/11/1996 | CA2206998A1 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| 07/11/1996 | CA2203632A1 A chitosan polymer having a specific degree of acetylation |
| 07/11/1996 | CA2184897A1 Novel bioemulsifiers |
| 07/11/1996 | CA2184394A1 Urinastatin-containing suppository |
| 07/10/1996 | EP0720857A1 Syringe |